TapewireFind a company

person · Reporting owner

PFEIFFER GARY M

Disclosed activity across 3 companies

Tapewire entity
45406
SEC CIK
0001127304

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
QUEST DIAGNOSTICS INCDGX · Entity 2118DirectorMay 20, 2026May 21, 2026
TerraVia Holdings, Inc.TVIA · Entity 175855DirectorMay 22, 2017May 23, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QUEST DIAGNOSTICS INC

Report date May 20, 2026 · Filed May 21, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect31,005 Reported balance After 2026-05-20 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 31,005

F1: Represents an award of restricted stock units.

F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units.

F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

TerraVia Holdings, Inc.

Report date May 22, 2017 · Filed May 23, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.31 · Expires 2027-05-21Direct32,000 Reported balance After 2017-05-22 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2017-05-22 · Grant · Acquired 32,000 · Balance 32,000

F1: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Internap Corp

Report date May 08, 2020 · Filed May 08, 2020

Section 16 reporting ended · disclosed 2020-05-08. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2020-05-08 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2020-05-08 · Other · Disposed 80,695 · Balance 0

F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases.

F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements.

F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished.

Stock Option (right to buy)SEC Table II · derivative / convertible securityDirect0 Reported balance After 2020-05-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-05-08 · Other · Disposed 4,072 · Balance 0

F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.

Filing footnotes · ownership attribution and instrument terms

F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases.

F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements.

F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished.

F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 20, 2026 Filed May 21, 2026 20:52 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,142 $0.00 $0.00
Disclosure

SEC source: 0001127304-26-000002 · wk-form4_1779396728.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,005

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
October 23, 2025 Filed Oct 24, 2025 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherPhantom Stock · Derivative 4,413.284 $190.58 $841,083.66
Disclosure

SEC source: 0001022079-25-000228 · wk-form4_1761343851.xml · derivative · entry 2

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,413.284 shares

Expires not disclosed

F1 · derivative.exercise_price: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock.

F1 · derivative.exercise_date: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock.

F1 · derivative.expiration_date: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock.

F2 · derivative.underlying_shares: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
October 22, 2025 Filed Oct 24, 2025 22:10 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 1,482 $182.40 $270,316.80
Disclosure

SEC source: 0001022079-25-000228 · wk-form4_1761343851.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,431

Read SEC document
May 15, 2025 Filed May 19, 2025 20:20 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,203 $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000142 · wk-form4_1747686016.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,669

F1 · security: Represents an award of restricted stock units.

Read SEC document
May 16, 2024 Filed May 20, 2024 23:22 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,482 $0.00 $0.00
Disclosure

SEC source: 0001022079-24-000127 · wk-form4_1716247364.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,916

F1 · shares: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 17, 2023 Filed May 19, 2023 22:18 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,369 $0.00 $0.00
Disclosure

SEC source: 0001022079-23-000113 · wk-form4_1684534709.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,839

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 18, 2022 Filed May 20, 2022 20:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,292 $0.00 $0.00
Disclosure

SEC source: 0001022079-22-000093 · wf-form4_165307889530308.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,982

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes approximately 425 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 25, 2021 Filed May 25, 2021 20:50 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,363 $0.00 $0.00
Disclosure

SEC source: 0001022079-21-000096 · wf-form4_162197577446252.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,265

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:40 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001022079-20-000125 · wf-form4_159009358467185.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,513

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 08, 2020 Filed May 8, 2020 16:41 UTC Internap Corp INAPQ · Entity 149167 OtherStock Option (right to buy) · Derivative 4,072 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-007236 · wf-form4_158897045301946.xml · derivative · entry 2

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Call Options (obligation to sell) · 0 shares

Expires not disclosed

F4 · derivative.exercise_price: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.

F4 · derivative.exercise_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.

F4 · derivative.expiration_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.

Read SEC document
May 08, 2020 Filed May 8, 2020 16:41 UTC Internap Corp INAPQ · Entity 149167 OtherCommon Stock 80,695 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-007236 · wf-form4_158897045301946.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases.

F2 · security: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements.

F3 · security: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 16:18 UTC Internap Corp INAP · Entity 149167 GrantCommon Stock 26,726 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-007852 · wf-form4_156019788821942.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,695

F1 · security: Reporting Person received the restricted stock for annual director retainer.

F2 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant.

F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 14, 2019 Filed May 16, 2019 20:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,722 $0.00 $0.00
Disclosure

SEC source: 0001022079-19-000140 · wf-form4_155803930519861.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,563

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
November 12, 2018 Filed Nov 14, 2018 16:52 UTC Internap Corp INAP · Entity 149167 PurchaseCommon Stock 10,000 $6.56 $65,600.00
Disclosure

SEC source: 0001628280-18-014372 · wf-form4_154223232939214.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,969

F1 · security: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.48 to $6.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.

Read SEC document
September 30, 2018 Filed Oct 2, 2018 20:01 UTC Internap Corp INAP · Entity 149167 GrantCommon Stock 1,819 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-012222 · wf-form4_153852487391921.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,969

F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 30, 2018 Filed Jul 3, 2018 16:35 UTC Internap Corp INAP · Entity 149167 GrantCommon Stock 1,316 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-009078 · wf-form4_153065009588271.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,150

F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 07, 2018 Filed Jun 11, 2018 20:59 UTC Internap Corp INAP · Entity 149167 GrantCommon Stock 9,557 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-007801 · wf-form4_152876517195219.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,834

F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 15, 2018 Filed May 17, 2018 21:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,644 $0.00 $0.00
Disclosure

SEC source: 0001022079-18-000119 · wf-form4_152659250386907.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,462

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
April 05, 2018 Filed Apr 9, 2018 16:19 UTC Internap Corp INAP · Entity 149167 Tax withholdingCommon Stock 66 $11.07 $730.62
Disclosure

SEC source: 0001628280-18-004112 · wf-form4_152330515633264.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,211

F1 · security: Shares of common stock withheld by Issuer to satisfy minimum statutory tax obligations on vesting of restricted stock.

Read SEC document
March 31, 2018 Filed Apr 3, 2018 16:20 UTC Internap Corp INAP · Entity 149167 GrantCommon Stock 802 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-003945 · wf-form4_152278680860075.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,277

F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 16:28 UTC Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 557 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-000088 · wf-form4_151501487267913.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,475

F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

F3 · balance_after: On November 20, 2017, the Issuer effected a 1-for-4 reverse stock split of its Common Stock. The amount of securities reported as beneficially owned in this Form 4 has been adjusted to reflect the reverse stock split.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 16:47 UTC Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 2,011 $0.00 $0.00
Disclosure

SEC source: 0001628280-17-009630 · wf-form4_150706362761755.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,668

F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 09:16 UTC Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 32,258 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 3

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,657

F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

F4 · security: One hundred percent of the shares of restricted common stock will vest on the date of the issuer's annual meeting of stockholders to be held in 2018.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 09:16 UTC Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 4,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 2

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,399

F2 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant.

F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 21, 2017 Filed Jun 23, 2017 09:16 UTC Internap Corp INAP · Entity 149167 Tax withholdingRestricted Common Stock 7,817 $3.44 $26,890.48
Disclosure

SEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,122

F1 · kind: Shares withheld to satisfy minimum statutory tax obligations on vesting of restricted stock.

Read SEC document
June 21, 2017 Filed Aug 24, 2017 18:11 UTC Amendment Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 32,258 $0.00 $0.00
Disclosure

SEC source: 0001628280-17-008884 · wf-form4a_150361268338316.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,657

F1 · security: The Form 4 originally filed on June 23, 2017 incorrectly reported the vesting period for the Restricted Common Stock. This amendment reports the correct vesting period for the Restricted Common Stock, which is one hundred percent of the shares vest on the one year anniversary of the date of grant.

Read SEC document
May 22, 2017 Filed May 23, 2017 20:56 UTC TerraVia Holdings, Inc. TVIA · Entity 175855 GrantStock Option (right to buy) · Derivative 32,000 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001555667-17-000016 · edgar.xml · derivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2027-05-21

F1 · derivative.exercise_date: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017.

Read SEC document
May 16, 2017 Filed May 18, 2017 20:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001022079-17-000137 · wf-form4_149514027887403.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,534

F1 · security: Represents an award of restricted share units granted on May 16, 2017.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
April 05, 2017 Filed Apr 7, 2017 18:11 UTC Internap Corp INAP · Entity 149167 GrantRestricted Common Stock 784 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-026347 · doc4.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,939

F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant.

F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionStock Options (Right to Buy) · Derivative 6,111 $0.00 Strike: $61.23 $0.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 16

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,111 shares

Expires 2023-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionStock Options (Right to Buy) · Derivative 6,111 $0.00 Strike: $57.57 $0.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 15

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,111 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionStock Options (Right to Buy) · Derivative 6,111 $0.00 Strike: $57.67 $0.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 14

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,111 shares

Expires 2021-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionStock Options (Right to Buy) · Derivative 8,000 $0.00 Strike: $55.76 $0.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 13

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionStock Options (Right to Buy) · Derivative 8,000 $0.00 Strike: $51.55 $0.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 12

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2019-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 8,310 $85.25 $708,460.74
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 11

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,698

F6 · price: This transaction was executed in multiple trades at prices ranging from $85.11 to $85.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 6,111 $85.18 $520,559.42
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 10

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,008

F5 · price: This transaction was executed in multiple trades at prices ranging from $85.09 to $85.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 6,111 $61.23 $374,145.98
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 9

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 6,111 $85.09 $519,972.77
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 8

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,008

F4 · price: This transaction was executed in multiple trades at prices ranging from $85.01 to $85.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 6,111 $57.57 $351,779.72
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 7

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 6,111 $85.07 $519,832.22
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 6

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,008

F3 · price: This transaction was executed in multiple trades at prices ranging from $85.01 to $85.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 6,111 $57.67 $352,390.82
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 5

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 8,000 $84.94 $679,504.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 4

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,008

F2 · price: This transaction was executed in multiple trades at prices ranging from $84.82 to $84.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 8,000 $55.76 $446,080.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 3

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 8,000 $85.01 $680,096.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 2

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,008

F1 · price: This transaction was executed in multiple trades at prices ranging from $84.96 to $85.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 22:25 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 8,000 $51.55 $412,400.00
Disclosure

SEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 1

PFEIFFER GARY M · CIK 0001127304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.